NIH-funded research NIH-funded research

Understanding how cells recycle mitochondria with their own DNA

Official title: Understanding the regulation and function of autophagy of mitochondria containing mtDNA

Funded at Thomas Jefferson University · NIH-11467359 · Data updated 2026-11-12

Scientists are studying how cells quietly remove mitochondria that contain their own DNA, a process that could influence cancer biology and cell health.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionThomas Jefferson University
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startSeptember 1, 2026
Project endApril 30, 2031
Funding year2026
Award (this year)$392,500
NIH project number1R35GM167167-01
Project IDNIH-11467359 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are patients whose cancers exhibit alterations in mitochondrial biology or autophagy pathways and could potentially benefit from therapies targeting mitochondrial turnover.

Less likely to help

Patients without cancers or those whose tumors do not involve the studied autophagy pathways may not benefit.

What this research studies

This project looks at a specialized form of autophagy that targets mitochondria with mtDNA, aiming to understand when and why it happens and how it differs from regular mitophagy. By examining the cellular signals and regulatory pathways, researchers hope to map how AuMiD choices affect cell metabolism and stress responses in cancer-related contexts. The work combines cell biology methods with molecular analyses to describe how mtDNA-containing mitochondria are recognized and degraded. Results could reveal new angles on how cancer cells manage their energy and survive stress. The findings may guide future therapies that modulate mitochondrial quality control in tumors.

Why it matters

Potential benefit: If successful, this research could identify new targets to influence cancer cell survival and inflammation through mitochondrial quality control.

How similar studies have gone: Previous work has shown autophagy-related processes influence cell survival, with some approaches translating to cancer models, but AuMiD is a newer concept with limited clinical translation so far.

Where this research is happening

  • Thomas Jefferson University
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Goldsmith, Juliet — Thomas Jefferson University
  • Study coordinator: Goldsmith, Juliet

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.